Capturing the spatiotemporal spread of COVID-19 in 30 European countries during 2020 – 2022.

Capturing the spatiotemporal spread of COVID-19 in 30 European countries during 2020 – 2022.

Publication date: Oct 21, 2025

While the COVID-19 pandemic has been burdensome globally, it has fostered extensive data collection at various spatiotemporal resolutions. These data heightened researchers’ interest in investigating multiple facets of the pandemic. In Europe, key factors shaping disease transmission vary among countries, leading to a gap in understanding how the epidemic evolved and spread across countries as a whole. We endeavor to understand the similarities and differences in the spatiotemporal spread of the COVID-19 pandemic across 27 European Union (EU) countries and 3 European Economic Area (EEA) countries between March 2020 and December 2022. We utilized a multivariate endemic-epidemic model to conduct a space-time analysis across 30 countries, using weekly aggregated COVID-19 case counts from week 13-2020 to week 50-2022. Our analysis considered the discrepancies in population size, the primary course and three booster vaccine doses – taking into account waning immunity, the Stringency Index as a surrogate for non-pharmaceutical interventions adopted in each country, and the circulation of various viral variants. We employed a power law approximation for spatial interactions between countries. We found that within-country transmission was dominant across all countries over almost three years of observation. This work also underscored a basic transmission mechanism, whereby infections introduced by between-country transmission could be of great importance in subsequent local transmission. Furthermore, there were indications of the transition to endemicity since the beginning of 2022, particularly in light of the evolving variants of concern. Our study highlighted the benefit of the endemic-epidemic framework to elucidate the COVID-19 disease spread over a large spatial and temporal scale, using a wide range of epidemiological information. Insights derived from this study are beneficial for those interested in seeking an overview of the emergency phase of the COVID-19 pandemic in the EU/EEA region.

Open Access PDF

Concepts Keywords
December COVID-19
Pandemic COVID-19
Researchers Endemic-epidemic
Viral Europe
Europe
European Union
Humans
Pandemics
SARS-CoV-2
Spatio-Temporal Analysis
Spatiotemporal

Semantics

Type Source Name
disease MESH COVID-19
disease IDO country
disease MESH infections
disease MESH emergency
pathway REACTOME Reproduction
disease MESH Infectious Diseases
drug DRUGBANK Stavudine
disease IDO infection
drug DRUGBANK Coenzyme M
drug DRUGBANK Trestolone
drug DRUGBANK Albendazole
disease IDO infectivity
disease IDO susceptible population
disease IDO symptom
drug DRUGBANK Aspartame
drug DRUGBANK Ranitidine
drug DRUGBANK L-Valine
disease IDO process
drug DRUGBANK Pentaerythritol tetranitrate
disease MESH endemic disease
disease MESH re infection
disease IDO history
disease IDO susceptibility
disease MESH measles
pathway KEGG Measles
drug DRUGBANK Serine
drug DRUGBANK Methenamine

Original Article

(Visited 14 times, 1 visits today)

Leave a Comment

Your email address will not be published. Required fields are marked *